Altered (oxidized) C1q induces a rheumatoid arthritis-like destructive and chronic inflammation in joint structures in arthritis-susceptible rats

Clinical Immunology and Immunopathology

Volumn 82, Issue 2, 1997, Pages 149-156

  Trinder, Peter K E ^b   Maeurer, Markus J ^b   Stoerkel, Stefan S ^a   Loos, Michael ^b  

^a Institute of Pathology   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; COMPLEMENT COMPONENT C1Q;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

EID: 0031081250     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.4293     Document Type: Article

References (39)

1. 1. Beard, H. K., Ryvar, R., Skingle, J., and Greenbury, C. L., Anti-collagen antibodies in sera from rheumatoid arthritis patients. J. Clin. Pathol 30, 1077-1081, 1980.
2. 2. Clague, R. B., and Moore, L. J., IgG and IgM antibody to native type II collagen in rheumatoid arthritis serum and synovial fluid: Evidence for the presence of collagen-anti-collagen immune complexes in synovial fluid. Arthritis Rheum. 27, 1371-1377, 1984.
3. 3. Tarkowski, A., Klareskog, L., Carlsten, H., Herberts, P., and Koopman, W. J., Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum. 32, 1087-1092, 1989.
4. 4. Maeurer, M. J., Trinder, P. K. E., Störkel, S., and Loos, M., C1q in autoimmune diseases: Rheumatoid arthritis. Behring Inst. Mitt. 93, 262-278, 1993.
5. 5. Trinder, P. K. E., Maeurer, M. J., Brackertz, D., and Loos, M., The collagen-like component of the complement system, C1q, is recognized by 7S autoantibodies and is functionally impaired in synovial fluids of patients with rheumatoid arthritis. Immunology 87, 355-361, 1996.
6. 6. Antes, U., Heinz, H.-P., and Loos, M., Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic Lupus erythematosus. Arthritis Rheum. 31, 457-464, 1988.
7. 7. Heinz, H.-P., Brackertz, D., and Loos, M., Enzymatic alteration of C1q, the collagen-like subcomponent of the first component of complement, leads to cross-reactivity with type II collagen. FEBS Lett. 228, 332-336, 1988.
8. 8. Lunec, J., Halloran, S. P., White, A. G., and Dormandy, T. L., Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J. Rheumatol. 8, 233-245, 1981.
9. 9. Burkhardt, H., Schwingel, M., Menninger, H., Macartney, H. W., and Tschesche, H., Oxygen radicals as effectors of cartilage destruction: Direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes. Arthritis Rheum. 29, 379-387, 1986.
10. 10. Trentham, D. E., Townes, A. S., and Kang, A. H., Autoimmunity to type II collagen: An experimental model of arthritis. J. Exp. Med. 146, 857-868, 1977.
11. 11. Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A., and Mosedale, B., Immunization against heterologous type II collagen induces arthritis in mice. Nature 283, 666-668, 1980.
12. 12. Larsson, P., Kleinau, S., Holmdahl, R., and Klareskog, L., Homologous type II collagen-induced arthritis in rats: Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation. Arthritis Rheum. 33, 693-701, 1990.
13. 13. Cathcart, E. S., Hayes, K. C., Gonnerman, W. A., Lazzari, A. A., and Franzblau, C., Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen. Lab. Invest. 54, 26-31, 1986.
14. 14. Terato, K., Hasty, K. A., Cremer, M. A., Stuart, J. M., Townes, A. S., and Kang, A. H., Collagen-induced arthritis in mice: Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J. Exp. Med. 162, 637-646, 1985.
15. 15. Myers, L. K., Stuart, J. M., Seyer, J. M., and Kang, A. H., Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis. J. Exp. Med. 170, 1999-2010, 1989.
16. 16. Ku, G., Kronenberg, M., Peacock, D. J., Tempst, P., Banquerigo, M. L., Braun, B. S., Reeve, J. R., Jr., and Brahn, E., Prevention of experimental autoimmune arthritis with a peptide fragment of type II collagen. Eur. J. Immunol. 23, 591-599, 1993.
17. 17. Maeurer, M. J., Trinder, P. K. E., Störkel, S., and Loos, M., Modulation of type II collagen-induced arthritis in DBA/1 mice by intravenous application of a peptide from the C1q A-chain. Immunobiol. 185, 103-120, 1992.
18. 18. Morgan, K, Clague, R. B., Shaw, M. J., Firth, S. A., Twose, T. M., and Holt, P. J. L., Native type II collagen induced arthritis in the rat: The effect of complement depletion by cobra venom factor. Arthritis Rheum. 24, 1356-1362, 1981.
19. 19. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the folin phenol reagent. J. Biol. Chem. 139, 265-275, 1951.
20. 20. Stemmer, F., and Loos, M., Purification and characterization of human, guinea pig and mouse C1q by fast protein liquid chromatography (FPLC). J. Immunol. Methods 74, 9-16, 1984.
21. 21. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685, 1970.
22. 22. Mayne, R., Cartilage collagens: What is their function, and are they involved in articular disease? Arthritis Rheum. 32, 241-246, 1989.
23. 23. Allard, S. A., Bayliss, M. T., and Maini, R. N., The synovium-cartilage junction of the normal human knee: Implications for joint destruction and repair. Arthritis Rheum. 33, 1170-1179, 1990.
24. 24. Bohnsack, J. F., Tenner, A. J., Laurie, G. W., Kleinman, H. J., Martin, G. R., and Brown, E. J., The C1q subunit of the first component of complement binds to laminin: A mechanism for the deposition and retention of immune complexes in basement membrane. Proc. Natl. Acad. Sci. USA 82, 3824-3828, 1985.
25. 25. Carsons, S. E., Schwartzman, S., Diamond, H. S., and Berkowitz, E., Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma. Clin. Exp. Immunol. 72, 37-42, 1988.
26. 26. Almeda, S., Rosenberg, R. D., and Bing, D. H., The binding properties of human complement component C1q. Interaction with mucopolysaccharides. J. Biol. Chem. 258, 785-791, 1983.
27. 27. Clark, R. A., Dvorak, H. F., and Colvin, R. B., Fibronectin in delayed-type hypersensitivity skin reactions: Associations with vessel permeability and endothelial cell activation. J. Immunol. 126, 787-793, 1981.
28. 28. Breitner, S., Störkel, S., Reichel, W., and Loos, M., Complement components C1q, C1r/C1s and C11NH in rheumatoid arthritis: Correlation of in situ hybridization and Northern blot results with function and protein concentration in synovium and primary cell cultures. Arthritis Rheum. 38, 492-498, 1995.
29. 29. Schwaeble, W., Schäfer, M. K., Petry, F., Fink, T., Knebel, D., Weihe, E., and Loos, M., Follicular dendritic cells, interdigitating cells and cells of the monocyte-macrophage lineage are the C1q producing sources in the spleen. Identification of specific cell types by in situ hybridization and immunochemical analysis. J. Immunol. 155, 4971-4978, 1995.
30. 30. Holmdahl, R., C. Vingsbo, C., Mo, J. A., Michaelsson, E., Malmström, V., Jansson, L., and Brunsberg, U., Chronicity of tissue-specific experimental autoimmune disease: A role for B cells? Immunol. Rev. 144, 109-135, 1995.
31. 31. Mo, J. A., B Cell Recognition of type II collagen in mouse cartilage. Thesis, Medical Faculty, Uppsala University, Sweden, 1994.
32. 32. Bedwell, A. E., Elson, C. J., Carter, S. D., Dieppe, P. A., Hutton, C. W., and Czudek, R., Isolation and analysis of complement activating aggregates from synovial fluids of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies. Ann. Rheum. Dis. 46, 55-64, 1987.
33. 33. Colten, H. R., and Strunk, R. C., Synthesis of complement components in liver and at extra hepatic sites. In "Complement in Health and Disease" (K. Whaley, M. Loos, and J. Weiler, Eds.), pp. 127-158, Kluwer, Lancaster, UK, 1993.
34. 34. Zvaifler, N. J., and Firestein, G. S., Pannus and panocytes: Alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum. 37, 783-789, 1994.
35. 35. Klareskog, L., Holmdahl, R., Larsson, E., and Wigzell, H., Role of T lymphocytes in collagen II induced arthritis in rats. Clin. Exp. Immunol. 51, 117-125, 1983.
36. 36. Holmdahl, R., Rubin, K., Klareskog, L., Dencker, L., Gustafsson, G., and Larsson, E., Appearance of different lymphoid cells in synovial tissue and in peripheral blood during the course of collagen II-induced arthritis in rats. Scand. J. Immunol. 21, 197-204, 1985.
37. 37. Siegling, A., Buchner, E., Höflich, C., Kinne, R. W., and Emmrich, F., Predominance of Th1-like cytokine gene expression in the synovial membrane of rats with antigen-induced arthritis. The 9th International Congress of Immunology, Abstract Book, 634, 1995.
38. 38. Miltenburg, A. M. M., Dolhain, R. J. E. M., van der Heiden, A. N., and Breedfeld, F. C., Enhanced production of T helper (Th)-1, but not Th-2, cytokines by synovial fluid mononuclear cells (SFMC) compared with peripheral blood mononuclear cells (PBMC) of patients with rheumatoid arthritis (RA). The 9th International Congress of Immunology, Abstract Book, 842, 1995.
39. 39. Marcelletti, J. F., Ohara, J., and Katz, D. H., Collagen-induced arthritis in mice. Relationship of collagen-specific and total IgE synthesis to disease. J. Immunol. 147, 4185-4191, 1991.